Let’s Do More
for Patients, Together.
Freenome pursues a variety of partnerships across the healthcare ecosystem with the goal of ultimately improving care and expanding access to the patients we will serve.
Partner with FreenomeCollaborating Across Healthcare
Our commitment to innovation and quality relationships leads to longstanding and valuable partnerships, which truly make lasting impact through clinical studies, targeted applications of our multiomics platform, quality improvement initiatives, and more.
Biopharma Partners
Putting patients first means we’re compelled to also champion the research and development of early stage treatments and precision therapies throughout the care continuum.
We partner with biopharma companies with shared goals to leverage our platform’s capabilities to develop targeted therapies through:
- Biomarker discovery
- Treatment monitoring
- Predicting treatment response
- Minimal residual disease (MRD) detection
- Multiomics data generation in new disease areas
A Selection of Our Work with Biopharma Partners
Siemens Healthineers
To Identify to Suitable Markers for Early Breast Cancer DetectionMerck KGaA, Darmstadt, Germany
To Identify Signatures of Non-Small Lung CancerHealthcare Partners
Our partnerships with organizations throughout the healthcare ecosystem—from academic institutions, to healthcare systems, providers, health plans, and more—are critical to advance early detection technology for patients and ensure that our tests are seamlessly integrated into clinical care and accessible by all.
- Clinical study sites
- Quality improvement partners
- Research partners
A Selection of Our Work with Healthcare Partners
Morehouse School of Medicine
To Increase Clinical Study Participation Among Black PatientsOracle Cerner and Elligo Health Research
To Increase Access to Cancer Clinical TrialsAdvocacy & Industry Partners
Some of the most impactful work that we conduct is performed with those who have been advocating for and supporting patients directly, most especially with our focus on health equity. We know that these partnerships are critical to making an impact in patients’ lives, and we welcome the opportunity to work together in the pursuit of early cancer detection.
Contact Partnerships teamA Selection of Advocacy & Industry Partners
